Christopher Gu

1.1k total citations
17 papers, 695 citations indexed

About

Christopher Gu is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Christopher Gu has authored 17 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 11 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Christopher Gu's work include HIV Research and Treatment (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HIV/AIDS drug development and treatment (7 papers). Christopher Gu is often cited by papers focused on HIV Research and Treatment (12 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and HIV/AIDS drug development and treatment (7 papers). Christopher Gu collaborates with scholars based in United States and Canada. Christopher Gu's co-authors include Alon Herschhorn, Joseph Sodroski, Youdong Mao, Andrés Finzi, Liping Wang, Hillel Haim, Amos B. Smith, Shi-Hua Xiang, Xinzhen Yang and Luis R. Castillo-Menendez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Christopher Gu

17 papers receiving 693 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Gu United States 10 571 356 214 212 125 17 695
Hillel Haim United States 14 660 1.2× 499 1.4× 282 1.3× 256 1.2× 161 1.3× 29 942
Christopher A. Cottrell United States 14 346 0.6× 461 1.3× 241 1.1× 367 1.7× 212 1.7× 24 941
Daniel P. Leaman United States 14 459 0.8× 165 0.5× 223 1.0× 246 1.2× 200 1.6× 18 567
Claudia Blattner Netherlands 4 882 1.5× 301 0.8× 425 2.0× 492 2.3× 386 3.1× 4 1.1k
Nerea Huarte Spain 16 374 0.7× 117 0.3× 159 0.7× 413 1.9× 112 0.9× 24 684
Michael Golabek United States 8 966 1.7× 287 0.8× 410 1.9× 518 2.4× 439 3.5× 8 1.1k
Kaneil K. Zadrozny United States 11 550 1.0× 366 1.0× 92 0.4× 354 1.7× 30 0.2× 15 772
Jeffrey Copps United States 12 248 0.4× 194 0.5× 117 0.5× 256 1.2× 121 1.0× 24 511
Sara M. O’Rourke United States 15 210 0.4× 182 0.5× 172 0.8× 280 1.3× 141 1.1× 37 579
Jacob Korzun United States 5 901 1.6× 282 0.8× 402 1.9× 453 2.1× 414 3.3× 7 1.1k

Countries citing papers authored by Christopher Gu

Since Specialization
Citations

This map shows the geographic impact of Christopher Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Gu more than expected).

Fields of papers citing papers by Christopher Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Gu. The network helps show where Christopher Gu may publish in the future.

Co-authorship network of co-authors of Christopher Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Gu. A scholar is included among the top collaborators of Christopher Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Gu. Christopher Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gu, Christopher, Ayannah S. Fitzgerald, Jevon Graham-Wooten, et al.. (2023). Tracking gut microbiome and bloodstream infection in critically ill adults. PLoS ONE. 18(10). e0289923–e0289923. 2 indexed citations
2.
Redding, Laurel E., Arwa Abbas, Joseph P. Zackular, et al.. (2022). Genetic and phenotypic characteristics of Clostridium (Clostridioides) difficile from canine, bovine, and pediatric populations. Anaerobe. 74. 102539–102539. 7 indexed citations
3.
Gu, Christopher, et al.. (2020). Slow Receptor Binding of the Noncytopathic HIV-2UC1 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity. Cell Reports. 31(10). 107749–107749. 13 indexed citations
4.
Gu, Christopher, Chunyu Zhao, Casey E. Hofstaedter, et al.. (2020). Investigating hospital Mycobacterium chelonae infection using whole genome sequencing and hybrid assembly. PLoS ONE. 15(11). e0236533–e0236533. 5 indexed citations
5.
Gu, Christopher, Joshua E. Denny, Susan C. Broadaway, et al.. (2020). Detection and elimination of a novel non-toxigenic Clostridioides difficile strain from the microbiota of a mouse colony. Gut Microbes. 12(1). 1851999–1851999. 6 indexed citations
6.
Gu, Christopher, David E. Lucero, Chaorui Huang, et al.. (2018). Pneumonia-Associated Hospitalizations, New York City, 2001-2014. Public Health Reports. 133(5). 584–592. 6 indexed citations
7.
Nguyen, Hanh T., Navid Madani, Haitao Ding, et al.. (2017). Evaluation of the contribution of the transmembrane region to the ectodomain conformation of the human immunodeficiency virus (HIV-1) envelope glycoprotein. Virology Journal. 14(1). 33–33. 9 indexed citations
8.
Herschhorn, Alon, Christopher Gu, Francesca Moraca, et al.. (2017). The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions. Nature Communications. 8(1). 1049–1049. 75 indexed citations
9.
Pacheco, Beatriz, Nirmin Alsahafi, Olfa Débbeche, et al.. (2016). Residues in the gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by gp120-Directed Inhibitors. Journal of Virology. 91(5). 44 indexed citations
10.
Herschhorn, Alon, Xiaochu Ma, Christopher Gu, et al.. (2016). Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins. mBio. 7(5). 118 indexed citations
11.
Go, Eden P., Alon Herschhorn, Christopher Gu, et al.. (2015). Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140. Journal of Virology. 89(16). 8245–8257. 78 indexed citations
12.
Herschhorn, Alon, Christopher Gu, Nicole Espy, et al.. (2014). A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry. Nature Chemical Biology. 10(10). 845–852. 65 indexed citations
14.
Mao, Youdong, Liping Wang, Christopher Gu, et al.. (2013). Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Proceedings of the National Academy of Sciences. 110(30). 12438–12443. 76 indexed citations
15.
Mao, Youdong, Luis R. Castillo-Menendez, Liping Wang, et al.. (2013). Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer. Retrovirology. 10(S1). O1–P114. 6 indexed citations
16.
Mao, Youdong, Liping Wang, Christopher Gu, et al.. (2012). Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer. Nature Structural & Molecular Biology. 19(9). 893–899. 123 indexed citations
17.
Désormeaux, Anik, Mathieu Coutu, Halima Medjahed, et al.. (2012). The Highly Conserved Layer-3 Component of the HIV-1 gp120 Inner Domain Is Critical for CD4-Required Conformational Transitions. Journal of Virology. 87(5). 2549–2562. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026